Consuming Colorful Produce May Reduce AECOPD, Inflammation
Higher carotenoid levels from red, yellow, and orange fruits and veggies may reduce COPD exacerbations and inflammation.
Category: COPD
COPD
Latest
Consuming Colorful Produce May Reduce AECOPD, Inflammation
Higher carotenoid levels from red, yellow, and orange fruits and veggies may reduce COPD exacerbations and inflammation.
Read More
Merck Ph3 Trial to Evaluate Ensifentrine for AECOPD
Merck has begun patient enrollment in the ENHANCE-3 clinical trial to evaluate ensifentrine (Ohtuvayre) for preventing acute exacerbations of COPD.
Read More
Worse COPD Outcomes With Combined Cigarette, Biomass Smoke
Combined cigarette and biomass smoke exposure was associated with worse COPD outcomes, including more severe exacerbations.
Read More
Mepolizumab Reduced Corticosteroid Use in COPD Patients
Analysis of Phase 3 clinical trials shows mepolizumab cuts annual steroid exposure and high-dose treatment days for COPD patients.
Read More
Walking Benefits COPD Patients Even in Areas with High Air Pollution
Physical activity reduces COPD symptom flare-ups regardless of local air quality levels.
Read More
Cryospray Improved COPD Symptoms
Clinical trial results showed CSA Medical’s Metered CryoSpray procedure significantly eases chronic lung symptoms and lowers severe hospital events.
Read More
Cryospray Improved Chronic Bronchitis Symptoms
Patients with chronic bronchitis experienced better quality of life and fewer severe hospitalizations after Metered CryoSpray (MCS) therapy.
Read More
$3.5M to Fund Dyspnea Research for COPD, Ventilated Patients
Researchers are developing an automated tool to identify respiratory discomfort when ventilated patients are unable to communicate.
Read More
Military Blast Exposure Tied to Respiratory, Neurological Conditions
Veterans exposed to high-level explosive blasts face higher rates of emphysema, chronic bronchitis, and stroke years after service.
Read More
COPD Origins Tied to Early Child Lung Development, Air Pollution
Children with an inherited risk for COPD show slower lung growth when exposed to higher levels of air pollution during early childhood.
Read More
Laughter Therapy Comparable to Breathing Exercises for COPD Patients
Deliberate laughter therapy exercises are as effective as traditional breathing techniques for improving symptoms and overall health.
Read More
Semaglutide Tied to Fewer Asthma, COPD Exacerbations
The diabetes and weight loss injection semaglutide was associated with fewer asthma attacks and COPD exacerbations, according to ERS 2026 research.
Read More
High-dose Flu Vaccine Cuts Senior Hospitalizations
A high-dose vaccine reduced hospital admissions for flu or pneumonia by nearly 9% among older individuals with chronic respiratory conditions like asthma and COPD.
Read More
Insurance Barriers Limit Pulmonary Rehab Access
Insurance coverage is a significant barrier to accessing virtual pulmonary rehabilitation programs for people with COPD.
Read More
Azithromycin vs Roflumilast for AECOPD
A UCLA Health study compared azithromycin and roflumilast in protecting against acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
Read More
COPD Foundation to Host Patient-Focused Drug Development Meeting
The COPD Foundation announced an upcoming meeting to ensure patient experiences and priorities are incorporated into the future of therapeutic development.
Read More
Rapid Test for COPD Exacerbations Begins Study
ProAxsis and Imperial College London are investigating the NEATstik test, which detects active neutrophil elastase (NE) in sputum samples.
Read More
bioAffinity, Pictor Collaborate on Asthma and COPD Tests
The collaboration will combine flow cytometry and proteomic analysis to help ID specific inflammatory pathways for chronic lung diseases.
Read More
Testosterone Treatment Linked to Reduced Inhaled Steroid Use
Men receiving systemic testosterone therapy showed a statistically significant decrease in inhaled corticosteroid use starting 18 to 24 months after treatment initiation.
Read More
Daily Walks Near Traffic Pollution Increased COPD Cough, Sputum
Traffic-related air pollution can worsen respiratory symptoms during daily exercise for people with chronic lung disease.
Read More
Twice-yearly COPD Biologic Begins Trial
Windward Bio is evaluating WIN378, a monoclonal antibody designed for twice-yearly dosing in patients with moderate-to-severe COPD.
Read More
Voice Changes May Help Monitor Asthma and COPD at Home
New research suggests acoustic speech features can identify respiratory exacerbations from the first day of onset.
Read More
American Lung Association Launches COPD Management Program
American Lung Association is launching a new initiative to help the more than 16 million people in the US living with COPD manage symptoms and improve quality of life.
Read More
Alpha-1 Antitrypsin Deficiency Drug Enters Ph3 Trial
Grifols enrolled the first patient in its Phase 3 SWIFT-SC clinical trial to evaluate its subcutaneous Alpha1-Proteinase Inhibitor for the treatment of alpha1-antitrypsin (AAT) deficiency.
Read More